510(k) device
Sonatherm 600I Ultrasonic Lesion Generating System
Misonix, Inc. · System, Ablation, Ultrasound And Accessories (NTB, Class II) · First FDA decision Jul 9, 2008, newest Jul 9, 2008Tumor ablation
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
2
Naming "Sonatherm 600I Ultrasonic"
MAUDE reports
0
Brand "Sonatherm 600I Ultrasonic", since 2015
PubMed studies
0
Mentioning "Sonatherm 600I Ultrasonic"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Sonatherm 600I Ultrasonic Lesion Generating System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
K070779 · Decided Jul 9, 2008 · 476 days after receipt
Device type: System, Ablation, Ultrasound And Accessories (NTB) · General & Plastic Surgery
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Sonatherm 600I Ultrasonic", any status and sponsor, newest update first.
Indiana UniversityAcademic, hospital or other
NCT02248389 · 4 participants · Start Sep 4, 2014 · Primary completion Jun 8, 2015
Device: Sonatherm 600i ablation system · For: Carcinoma, Renal Cell
Sites: Indianapolis, Indiana
University of Southern CaliforniaAcademic, hospital or other
NCT02370342 · 0 participants · Start Dec 18, 2017 · Primary completion Dec 18, 2018
Device: Sonatherm 600i Ultrasonic Lesion Generating System · For: Renal Carcinoma; Renal Mass
Sites: Los Angeles, California · 2 sites in all
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Sonatherm 600I Ultrasonic", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code NTB
0 reports: 0 malfunction, 0 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Sonatherm 600I Ultrasonic"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code NTB.
- TheraVision Ultrasound Ablation System and ACOUSTx ApplicatorsAcoustic Medsystems, Inc. · 510(k) 2016
- Ultrazonix Spine Minimal-Invasive Disc SystemUltrazonix Dnt AB · 510(k) 2006
- Misonix Inc. Sonatherm 600 Ultrasonic Lesion Generating SystemMisonix, Inc. · 510(k) 2006
- Ultracinch Ablation DeviceEpicor Medical, Inc. · 510(k) 2004
- Epicor Medical Ablation SystemEpicor Medical, Inc. · 510(k) 2004
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.